Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Gaussian-based planning approach for robust dose-escalated stereotactic body proton therapy.

International journal of radiation oncology, biology, physics·2026
Same author

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
Same author

<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.

Radiology·2026
Same author

A digital twin framework for adaptive treatment planning in radiotherapy.

Physics in medicine and biology·2026
Same author

Efficient vision mamba for MRI super-resolution via hybrid selective scanning.

Medical physics·2026
Same author

Bladder activity of different PSMA PET radioligands and impact of furosemide.

American journal of nuclear medicine and molecular imaging·2026

Related Experiment Video

Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

MRI-guided neurovascular bundle avoidance in high dose rate prostate brachytherapy.

Drew G Gerber1, Sean Dresser1, Xiaofeng Yang1

  • 1Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

Brachytherapy
|January 13, 2026
PubMed
Summary

MRI-based treatment planning allows for neurovascular bundle (NVB)-sparing during high-dose-rate (HDR) prostate brachytherapy, preserving erectile function. This technique is feasible and warrants further investigation for improved patient outcomes.

Keywords:
Erectile dysfunctionHDR prostate brachytherapyNeurovascular bundleProstate cancer

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.4K

Related Experiment Videos

Last Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.4K

Area of Science:

  • Oncology
  • Radiotherapy
  • Urology

Background:

  • Neurovascular bundles (NVBs) are crucial for erectile function.
  • NVBs are poorly visualized with conventional imaging like ultrasound and CT.
  • Effective sparing of NVBs during prostate radiotherapy is challenging.

Purpose of the Study:

  • To investigate the feasibility of using treatment planning MRI to avoid NVBs during high-dose-rate (HDR) prostate brachytherapy.
  • To compare dose distributions between standard HDR brachytherapy plans and NVB-sparing plans.

Main Methods:

  • Retrospective review of 34 patients undergoing HDR prostate brachytherapy.
  • Contouring of left and right NVBs on treatment planning MRI.
  • Generation of standard and NVB-sparing treatment plans.
  • Dosimetric comparison of target coverage and organs at risk (OARs) between plan types.

Main Results:

  • NVB-sparing plans significantly reduced dose to the left and right NVBs (D0.01cc).
  • Prostate coverage (D90, V100) was maintained with NVB-sparing plans.
  • Slight reductions in prostate V150% and V200% were observed with NVB-sparing plans.
  • Doses to bladder, rectum, and urethra remained similar between plan types.

Conclusions:

  • MRI-based treatment planning enables feasible NVB-sparing during HDR prostate brachytherapy.
  • This approach shows promise for preserving erectile function in prostate cancer patients.
  • Further research is recommended to validate these findings.